Table 1.
HPV associated SCC | SCC (Conventional/ tobacco exposure) |
|
---|---|---|
Age (mean yrs) | 53 | 57 |
Sex | M>F 2.8:1 | M>F 1.5:1 |
Location | Tonsils, base of tongue>>nasopharynx | Oral cavity, larynx |
LN | 30-60% present at initial presentation Often cystic LN metastases Maybe bilateral |
Prognostic factor |
Prognosis (disease specific survival) | ||
3 yrs | 82% | 57% |
Morphology | Often non-keratinizing High nuclear to cytoplasmic ratio Relatively monotonous |
Usually keratinizing Surface dysplasia may be seen |
Associated with | HPV types 16>>18>others | Tobacco exposure |
Molecular
alterations |
High overexpressed p16* (IHC) Blocked Rb, p53 by viral E6, E7 HPV +high risk types 16>others |
LOH in Chr3p and/or Chr 9p and others Mutated p53 |
Chr=Chromosome; F=female; IHC=immunohistochemical evaluation; LOH=loss of heterozygosity; LN=lymph node metastases; M=males; yrs=years
p16 overexpression is not always associated with HPV status particularly outside of the oropharynx.